Lab Members

E. Courtney Henry joined the Kappadath Lab in February 2022 and is a postdoctoral fellow in the Department of Imaging Physics at MD Anderson Cancer Center.

My research focuses on quantitative imaging and radiation dosimetry in nuclear medicine with an emphasis on radioembolization therapy with 90Y-loaded microspheres. Within the context of 90Y radioembolization, my current interests include the development of a novel CT-based post-treatment dosimetry framework, the comparison of absorbed dose estimates between PET and SPECT imaging, dose kernel production through Monte Carlo radiation transport simulations, image-based activity quantification, and the relationship between microdosimetry and clinical outcomes.

Email: echenry@mdanderson.org
Phone: 713-563-3410
                                                 View: CV ORCID

Brian Kelley joined the Kappadath Lab in August 2022 and is currently pursuing a Medical Physics Specialized Master of Science degree at the Graduate School of Biomedical Sciences.

I am currently a Safety Specialist at the University of Texas MD Anderson Cancer Center and a Certified Health Physicist with 9 years of experience in health physics in both hospital and benchtop research realms. I obtained my B.S. in Radiological Health Engineering from Texas A&M University in 2013 and am a member of the National Health Physics Societies and the current President of the State of Texas Chapter of the Health Physics Society. My research interests are internal dosimetry and radiobiological implications in organ substructures and patient-specific treatment planning for radiopharmaceuticals.

Email: bmkelley@mdanderson.org
Phone: 713-563-3625

Benjamin P. Lopez joined the Kappadath Lab in August 2015 and is currently a Medical Physics Fellow with a Nuclear Medicine Emphasis in the Department of Imaging Physics Residency Program at MD Anderson Cancer Center.

My research interests revolve around improving quantification of radionuclide biodistribution in nuclear medicine and PET imaging and theranostic procedures to improve patient care. My Ph.D. dissertation “Absolute quantification of 99mTc activity distributions using a planar Molecular Breast Imaging commercial system” focused on evolving Molecular Breast Imaging as a complementary tool to mammography and ultrasound to better characterize breast cancer, to track disease progression, and to predict patient outcomes to neoadjuvant chemotherapy.

As a Medical Physics Fellow, I will continue to investigate the clinical applications of quantitative Molecular Breast Imaging in patient care.

                                                  Email: bplopez@mdanderson.org
                                                  Phone: 713-745-3647
                                                  View: CV ORCID